These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30595759)

  • 21. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
    Zhong Y; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteases-responsive nanomaterials for tumor targeting diagnosis and treatment.
    Xiong J; Gao H
    J Microencapsul; 2017 Aug; 34(5):440-453. PubMed ID: 28617063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.
    Yang Y; Chen Q; Li S; Ma W; Yao G; Ren F; Cai Z; Zhao P; Liao G; Xiong J; Yu Z
    J Biomed Nanotechnol; 2018 Aug; 14(8):1396-1408. PubMed ID: 29903055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate-conjugated and pH-responsive polymeric micelles for target-cell-specific anticancer drug delivery.
    Guan J; Zhou ZQ; Chen MH; Li HY; Tong DN; Yang J; Yao J; Zhang ZY
    Acta Biomater; 2017 Sep; 60():244-255. PubMed ID: 28713015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix Metalloproteinase Cleavable Nanoparticles for Tumor Microenvironment and Tumor Cell Dual-Targeting Drug Delivery.
    Sun Z; Li R; Sun J; Peng Y; Xiao L; Zhang X; Xu Y; Wang M
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):40614-40627. PubMed ID: 29095595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles.
    Cruz E; Kayser V
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides.
    Leng Q; Woodle MC; Mixson AJ
    Drugs Future; 2017 Feb; 42(2):95-104. PubMed ID: 28603338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer.
    Sun M; Guo J; Hao H; Tong T; Wang K; Gao W
    Theranostics; 2018; 8(10):2634-2645. PubMed ID: 29774064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microenvironment as the "regulator" and "target" for gene therapy.
    Wu J; Chen J; Feng Y; Tian H; Chen X
    J Gene Med; 2019 Jul; 21(7):e3088. PubMed ID: 30938916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
    Cerqueira BB; Lasham A; Shelling AN; Al-Kassas R
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):140-51. PubMed ID: 26515260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.
    van Vlerken LE; Amiji MM
    Expert Opin Drug Deliv; 2006 Mar; 3(2):205-16. PubMed ID: 16506948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternating block copolymer-based nanoparticles as tools to modulate the loading of multiple chemotherapeutics and imaging probes.
    Mattu C; Brachi G; Menichetti L; Flori A; Armanetti P; Ranzato E; Martinotti S; Nizzero S; Ferrari M; Ciardelli G
    Acta Biomater; 2018 Oct; 80():341-351. PubMed ID: 30236799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.
    Busatto S; Pham A; Suh A; Shapiro S; Wolfram J
    Biomed Microdevices; 2019 Apr; 21(2):46. PubMed ID: 30989386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.